Additionally, the promoting effect of HIF‐2α on NASH may be mediated by the NF‐κB signaling pathway, which facilitates the progression of NASH to liver fibrosis and increases the expression of inflammation‐related genes. This evidence concerns the gene EPAS1 and Hepatic fibrosis.